Padma Reddy

444 total citations
9 papers, 356 citations indexed

About

Padma Reddy is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Padma Reddy has authored 9 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Padma Reddy's work include Inflammatory Bowel Disease (2 papers), Asthma and respiratory diseases (2 papers) and Iron Metabolism and Disorders (2 papers). Padma Reddy is often cited by papers focused on Inflammatory Bowel Disease (2 papers), Asthma and respiratory diseases (2 papers) and Iron Metabolism and Disorders (2 papers). Padma Reddy collaborates with scholars based in United States, India and Poland. Padma Reddy's co-authors include Walter Spinelli, Andrew J. Dorner, Michael E. Burczynski, Lori Casciotti, Fred Immermann, Ron Peterson, Monette Cotreau, Natalie C. Twine, Andrew Strahs and Anandh Balasubramaniam and has published in prestigious journals such as Journal of the Neurological Sciences, Clinical & Experimental Allergy and Cancer Biology & Therapy.

In The Last Decade

Padma Reddy

9 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Padma Reddy United States 7 137 90 87 75 69 9 356
Katerina Kypreou Greece 10 156 1.1× 39 0.4× 72 0.8× 155 2.1× 55 0.8× 24 412
Masaru Koido Japan 12 226 1.6× 124 1.4× 48 0.6× 46 0.6× 52 0.8× 30 523
Akash Gupta United States 11 157 1.1× 77 0.9× 31 0.4× 100 1.3× 23 0.3× 41 412
Naiara G. Bediaga Australia 15 479 3.5× 111 1.2× 138 1.6× 95 1.3× 28 0.4× 29 762
Yangzhige He China 10 288 2.1× 53 0.6× 56 0.6× 104 1.4× 62 0.9× 21 527
Liang‐Ru Ke China 18 239 1.7× 23 0.3× 112 1.3× 291 3.9× 67 1.0× 37 767
Hui‐Min Lin United States 8 211 1.5× 36 0.4× 61 0.7× 82 1.1× 19 0.3× 13 385
Zexian Fu China 7 232 1.7× 39 0.4× 60 0.7× 127 1.7× 32 0.5× 10 388
M Krupp Germany 12 367 2.7× 41 0.5× 26 0.3× 73 1.0× 80 1.2× 25 552
Xiwen Cheng United States 13 321 2.3× 50 0.6× 78 0.9× 61 0.8× 34 0.5× 22 464

Countries citing papers authored by Padma Reddy

Since Specialization
Citations

This map shows the geographic impact of Padma Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Padma Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Padma Reddy more than expected).

Fields of papers citing papers by Padma Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Padma Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Padma Reddy. The network helps show where Padma Reddy may publish in the future.

Co-authorship network of co-authors of Padma Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Padma Reddy. A scholar is included among the top collaborators of Padma Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Padma Reddy. Padma Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Danto, Spencer I., Nikolaos Tsamandouras, Padma Reddy, et al.. (2024). Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis. Allergy Asthma and Clinical Immunology. 20(1). 46–46. 1 indexed citations
2.
Sandborn, William J., Silvio Danese, Jarosław Leszczyszyn, et al.. (2021). OP33 Oral ritlecitinib and brepocitinib in patients with Moderate to Severe Active Ulcerative Colitis: Data from the VIBRATO umbrella study. Journal of Crohn s and Colitis. 15(Supplement_1). S030–S031. 13 indexed citations
3.
Hassan‐Zahraee, Mina, Anindita Banerjee, John B. Cheng, et al.. (2017). Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn’s Disease. Journal of Crohn s and Colitis. 12(1). 77–86. 21 indexed citations
5.
Reddy, Padma, Umesh Srikantha, Balaram Thota, et al.. (2008). PBEF1/NAmPRTase/Visfatin: A potential malignant astrocytoma/glioblastoma serum marker with prognostic value. Cancer Biology & Therapy. 7(5). 663–668. 93 indexed citations
6.
Burczynski, Michael E., Ron Peterson, Natalie C. Twine, et al.. (2006). Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells. Journal of Molecular Diagnostics. 8(1). 51–61. 191 indexed citations
7.
Jelinsky, Scott A., Joy Miyashiro, Kathryn A. Saraf, et al.. (2005). Exploiting genotypic differences to identify genes important for EAE development. Journal of the Neurological Sciences. 239(1). 81–93. 11 indexed citations
8.
Reddy, Padma, et al.. (2001). Evaluation of efficacy and safety of iron polymaltose complex and folic acid (Mumfer) vs iron formulation (ferrous fumarate) in female patients with anaemia.. PubMed. 99(3). 154–5. 9 indexed citations
9.
Reddy, Padma, et al.. (2000). Mumfer (iron polymaltose complex) in the management of anaemia in pregnancy--an Indian study.. PubMed. 98(6). 343, 346–343, 346. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026